The Bulgarian pharmaceutical distributor Bulpharma is seeking antitrust approval for the acquisition of N Auto Sofia

SOFIA (Bulgaria), June 29 (SeeNews) – The Bulgarian Commission for the Protection of Competition (CPC) announced that local pharmaceutical distributor Bulpharma is requesting approval from Auto Union to acquire car dealer N Auto Sofia.

Interested parties have until July 2 to submit their comments on the transaction to the competition authority, said the CPC in a statement published on Friday.

Bulpharma’s latest financial report filed with the Commercial Register showed that the Bulpharma Group consisted of 27 companies at the end of 2018, including the parent company. The list includes companies in the healthcare, transportation, real estate, and hospitality sectors.

At the end of 2018, Bulpharma owned several hospitals in the country, including Sofia-based Sofiamed Hospital and Plovdiv-based Pulmed Hospital, five pharmacies, construction company Zavodski Stroezhi-PS-Pazardzhik, Pazardzhik-based public transport company Heburbus, and hotel operator Silver Hotel based in Sofia.

At the end of 2018, Bulpharma was 98.02% owned by private person Mihail Tikov, as the annual financial statements show.

N Auto Sofia was founded in 2003 and, according to the information published on its website, is an authorized dealer of Nissan automobiles and spare parts in Bulgaria.

Bulpharma, based in Peshtera, sells pharmaceuticals, medical devices and dietary supplements to hospitals, preclinical and medical centers as well as external pharmacies and has its own logistics center in the second largest city of Plovdiv. The company employs over 3,000 people, works with six hospitals and seven polyclinics, and has controlling interests in 31 companies, according to information published on the website.

(1 euro = 1,95583 lev)


Source link

About admin

Check Also

NCIPD: 21 districts in Bulgaria are Covid-19 red zones

Twenty-one of the 28 districts in Bulgaria are Covid-19 red zones, which, according to the …

Leave a Reply

Your email address will not be published. Required fields are marked *